John R. Beaver - Jun 11, 2021 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role: President & CEO, Director
Signature: /s/ Michael C. Carroll, attorney-in-fact for John R. Beaver
Stock symbol: BIOL
Transactions as of: Jun 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/14/2021, 09:35 PM
Previous filing: May 19, 2021
Next filing: Aug 13, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOL	Restricted Stock Unit	Award	$0	+4.14M		$0.00	4.14M	Jun 11, 2021	Common Stock	4.14M		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2	The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023, subject to performance-based vesting criteria as established by the Compensation Committee; provided that if the price of Common Stock on such vesting date is greater than $1.40 per share, one-half of the award amount above $1.40 shall be payable on the first anniversary of the vesting date, and one-half of such amount shall be payable on the second anniversary of the vesting date.

Content

At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.

The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023, subject to performance-based vesting criteria as established by the Compensation Committee; provided that if the price of Common Stock on such vesting date is greater than $1.40 per share, one-half of the award amount above $1.40 shall be payable on the first anniversary of the vesting date, and one-half of such amount shall be payable on the second anniversary of the vesting date.